Management of Bleeding in a Patient Taking an Anticoagulant or Antiplatelet Drug
General measures Stop the anticoagulant drug Document the timing and amount of the last drug dose and presence of pre-existing renal or hepatic impairment Estimate the half-life and length of functional defect induced by the drug Assess the source of bleeding Request full blood count, prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration, creatinine concentration If available, request a specific laboratory test to measure the antithrombotic effect of the drug Correct haemodynamic compromise with intravenous fluids and red cell transfusion Apply mechanical pressure, if possible Use endoscopic, radiological or surgical measures to achieve haemostasis |
Source: British Society for Haematology. Reproduced with permission of John Wiley & Sons.